Oral reference dose (RfD) derivation for five bisphenol A alternatives integrating BMD and NOAEL/LOAEL approaches
View abstract on PubMed
Summary
This summary is machine-generated.This study establishes crucial reference doses for five bisphenol A (BPA) alternatives, including bisphenol B (BPB) and bisphenol AF (BPAF). These findings provide vital data on the health risks of BPA substitutes, supporting public health protection.
Area Of Science
- Environmental Health
- Toxicology
- Endocrinology
Background
- Bisphenols (BPs), including bisphenol A (BPA), are prevalent in industrial applications and consumer products.
- BPA's endocrine-disrupting properties have led to regulatory restrictions due to adverse health effects.
- Increased use of BPA alternatives necessitates characterization of their toxicity.
Purpose Of The Study
- To derive reference doses (RfDs) for five BPA alternatives: bisphenol B (BPB), bisphenol P (BPP), bisphenol Z (BPZ), bisphenol AF (BPAF), and bisphenol AP (BPAP).
- To address the knowledge gap regarding the toxicity thresholds of commonly used BPA substitutes.
- To refine risk assessment methodologies for endocrine-disrupting chemicals.
Main Methods
- Integrated epidemiological data and animal experiments for toxicity assessment.
- Employed Benchmark Dose (BMD) modeling and NOAEL/LOAEL approaches to calculate RfDs.
- Utilized uncertainty analysis to quantify risk metrics and ensure robust estimations.
Main Results
- Derived BMD-based RfDs: BPB (1.05 μg/kg-bw/day), BPP (0.23 μg/kg-bw/day), BPZ (5.13 μg/kg-bw/day).
- Derived NOAEL/LOAEL-based RfDs: BPAF (0.04 ng/kg-bw/day), BPAP (2.31 ng/kg-bw/day).
- Quantified toxicity thresholds for key BPA alternatives.
Conclusions
- Established scientifically-derived reference doses for five BPA alternatives, enhancing risk assessment.
- Highlighted potential health risks associated with BPA substitutes, informing regulatory decisions.
- Provided evidence-based data to support public health policies and safeguard against chemical exposures.

